23 related articles for article (PubMed ID: 35219635)
1. Results of resection of forearm soft tissue sarcoma.
Nakata E; Fujiwara T; Kunisada T; Nakahara R; Katayama H; Itano T; Ozaki T
J Orthop Surg Res; 2023 Aug; 18(1):599. PubMed ID: 37580775
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the 7th and 8th version of the AJCC classification system for soft tissue sarcomas of extremities and trunk in patients with localised, intermediate or high-grade disease treated at European tertiary sarcoma centres.
Smolle MA; van de Sande M; Hayes A; Bergovec M; Smith HG; Liegl-Atzwanger B; Tunn PU; Niethard M; Windhager R; Szkandera J; Leithner A
Eur J Surg Oncol; 2021 Aug; 47(8):2182-2188. PubMed ID: 33865657
[TBL] [Abstract][Full Text] [Related]
3. Elevated Controlling Nutritional Status (CONUT) Score is Associated with Poor Long-term Survival in Patients with Low-grade Soft-tissue Sarcomas Treated with Surgical Resection.
Liang Y; Hou T; Que Y; Zhao B; Xiao W; Zhang X; Zhou Z
Clin Orthop Relat Res; 2019 Oct; 477(10):2287-2295. PubMed ID: 31107315
[TBL] [Abstract][Full Text] [Related]
4. Age-adjusted Charlson Comorbidity Index is a valuable prognostic tool in operable soft tissue sarcoma of trunk and extremities.
Telli TA; Alan O; Demircan NC; Sariyar N; Arikan R; Basoglu T; Yasar A; Celebi A; Isik S; Sofulu O; Erol B; Turkoz HK; Ozgen Z; Ercelep O; Dane F; Yumuk PF
Orthop Traumatol Surg Res; 2023 May; 109(3):103491. PubMed ID: 36455864
[TBL] [Abstract][Full Text] [Related]
5. Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas.
Squires MH; Ethun CG; Suarez-Kelly LP; Yu PY; Hughes TM; Shelby RD; Tran TB; Poultsides G; Charlson J; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Pollock RE; Grignol V; Cardona K; Howard JH
J Surg Res; 2020 Jan; 245():577-586. PubMed ID: 31494391
[TBL] [Abstract][Full Text] [Related]
6. Complete pathological response to neoadjuvant treatment is associated with better survival outcomes in patients with soft tissue sarcoma: Results of a retrospective multicenter study.
Bonvalot S; Wunder J; Gronchi A; Broto JM; Turcotte R; Rastrelli M; Papai Z; Radaelli S; Lindner LH; Shumelinsky F; Cubillo A; Rutkowski P; Demaire C; Strens D; Nalbantov G
Eur J Surg Oncol; 2021 Aug; 47(8):2166-2172. PubMed ID: 33676792
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in soft tissue sarcoma.
Maretty-Nielsen K
Dan Med J; 2014 Nov; 61(11):B4957. PubMed ID: 25370967
[TBL] [Abstract][Full Text] [Related]
8. Treating soft tissue sarcomas with adjuvant chemotherapy.
Patrikidou A; Domont J; Cioffi A; Le Cesne A
Curr Treat Options Oncol; 2011 Mar; 12(1):21-31. PubMed ID: 21384115
[TBL] [Abstract][Full Text] [Related]
9. Systemic Treatment of Soft Tissue Sarcomas in the Geriatric Population.
Weiss MC
Curr Treat Options Oncol; 2022 Jun; 23(6):855-863. PubMed ID: 35389146
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors for Occurrence and Relapse of Soft Tissue Sarcoma.
Weskamp P; Ufton D; Drysch M; Wagner JM; Dadras M; Lehnhardt M; Behr B; Wallner C
Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267581
[TBL] [Abstract][Full Text] [Related]
11. Comorbidity, body mass index, and performance status as prognostic factors in older patients with soft-tissue sarcoma.
Tamiya H; Imura Y; Wakamatsu T; Takenaka S
J Geriatr Oncol; 2022 Jun; 13(5):673-681. PubMed ID: 35219635
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
